Correlation Between Virpax Pharmaceuticals and Rani Therapeutics
Can any of the company-specific risk be diversified away by investing in both Virpax Pharmaceuticals and Rani Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virpax Pharmaceuticals and Rani Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virpax Pharmaceuticals and Rani Therapeutics Holdings, you can compare the effects of market volatilities on Virpax Pharmaceuticals and Rani Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virpax Pharmaceuticals with a short position of Rani Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virpax Pharmaceuticals and Rani Therapeutics.
Diversification Opportunities for Virpax Pharmaceuticals and Rani Therapeutics
0.87 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Virpax and Rani is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Virpax Pharmaceuticals and Rani Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rani Therapeutics and Virpax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virpax Pharmaceuticals are associated (or correlated) with Rani Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rani Therapeutics has no effect on the direction of Virpax Pharmaceuticals i.e., Virpax Pharmaceuticals and Rani Therapeutics go up and down completely randomly.
Pair Corralation between Virpax Pharmaceuticals and Rani Therapeutics
Given the investment horizon of 90 days Virpax Pharmaceuticals is expected to under-perform the Rani Therapeutics. In addition to that, Virpax Pharmaceuticals is 1.45 times more volatile than Rani Therapeutics Holdings. It trades about -0.16 of its total potential returns per unit of risk. Rani Therapeutics Holdings is currently generating about -0.05 per unit of volatility. If you would invest 146.00 in Rani Therapeutics Holdings on November 2, 2024 and sell it today you would lose (7.00) from holding Rani Therapeutics Holdings or give up 4.79% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virpax Pharmaceuticals vs. Rani Therapeutics Holdings
Performance |
| Timeline |
| Virpax Pharmaceuticals |
| Rani Therapeutics |
Virpax Pharmaceuticals and Rani Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virpax Pharmaceuticals and Rani Therapeutics
The main advantage of trading using opposite Virpax Pharmaceuticals and Rani Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virpax Pharmaceuticals position performs unexpectedly, Rani Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rani Therapeutics will offset losses from the drop in Rani Therapeutics' long position.| Virpax Pharmaceuticals vs. Revelation Biosciences | Virpax Pharmaceuticals vs. Palisade Bio | Virpax Pharmaceuticals vs. Virax Biolabs Group | Virpax Pharmaceuticals vs. Quoin Pharmaceuticals Ltd |
| Rani Therapeutics vs. Vincerx Pharma | Rani Therapeutics vs. Tenaya Therapeutics | Rani Therapeutics vs. Corvus Pharmaceuticals | Rani Therapeutics vs. Alx Oncology Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |